Skip to content

DISCLAIMER: This article is a SPONSORED Press Release and does not constitute Finbold's editorial content. Crypto assets/products involve significant risks. Do not invest unless you are prepared to lose your entire investment. For a full disclaimer, please click here.

Crypto Powerhouses: Kaspa (KAS) and Injective (INJ) To Rule the Bull Run, Pullix (PLX) Presale Gains Momentum Ahead of Launch

Press Releases

The DeFi market has potential tokens that could dominate the upcoming bull run. Two names that have gained attention are Kaspa (KAS) and Injective (INJ). Meanwhile, Pullix (PLX) is a rising presale star in Stage 5 that could surge by 100x in 2024. Keep reading to discover what makes this crypto ICO event so attractive that it has already raised over $3M. 

Kaspa News 

Recently, Kaspa (KAS) announced that the upcoming Testnet 11 is set to debut on January 7. This will showcase the new Rust codebase and a speed of 10 blocks per second, signaling a leap in performance. Regarding the Kaspa coin movement, its value has increased from $0.10 on January 4 to $0.11 on January 5. 

The technical analysis of Kaspa also shows a bullish trend, with its value sitting above the 21 and 50-day EMAs. Its Fear & Greed index rating also indicates a 72 (Greed) – a good bullish sign. Because of this, experts foresee the Kaspa coin trading at $0.13 by the end of February 2024. 

Trust Wallet Joins Injective (INJ) 

Meanwhile, there were some exciting Injective (INJ) developments as well. Notably, this DeFi project announced that Trust Wallet has officially joined its network as a validator. Its collaboration with Injective aims to push the growth of Injective’s ecosystem to new heights. After this Injective news, its value increased from $36.57 on January 4 to $38.84 on January 5. 

From a technical perspective, the Injective crypto could continue this upward trajectory. Its Fear & Greed index rating shows a 71 (Greed) rating while it has experienced 15/30 green trading days. Therefore, market analysts predict this altcoin could be worth $0.12 in February 2024. 

Pullix (PLX): One of the Best DeFi Coins 

Pullix (PLX) is also making headlines as it has raced into Stage 6 of its presale in under 4 weeks. Soon, the PLX native token’s value will rise, which has caused countless investors to flood this new ICO event. Over 60M tokens have been sold, helping Pullix raise $23M. 

At its core, Pullix will establish a hybrid DeFi trading platform that combines the best CEX and DEX features. As a result, you can expect to find deep liquidity, access to all asset classes (including cryptos) on one account, and self-custodial portfolio management. While this exchange is the main attraction, Pullix will also introduce other components: 

  • VaultX: A multichain yield optimizer will let users earn compound interest on their cryptocurrency holdings.
  • Copy Trading: This feature enables traders to replicate trades from other experienced traders in its ecosystem. 

The PLX native token is the primary fuel behind all these features. With its unique “Trade-to-Earn” model, those who stake PLX will receive a percentage of Pullix’s daily revenue. Additionally, if you hold the PLX token, you obtain discounts on trading fees and access to exclusive asset classes. 

It is currently worth just $0.08, but it is expected to launch at over $0.12. Those who bought it early on are enjoying a 75% ROI. Thanks to its ties to the Forex market, which Baby Pips claims is the biggest right now, its long-term growth is very high. Experts predict that PLX could surge by 580% before the presale ends and another 100x after it hits exchanges in Q1 of 2024. 

Can Pullix Compete With Kaspa and Injective?

When comparing all these altcoins, we notice that Pullix has a drastically lower market cap than Kaspa and Injective. Its market cap now sits at $14M, while KAS has $2.5B and INJ has $3.2B. In other words, PLX will experience a surge much faster as it only needs $14M for its current price to double. Thus, Pullix is the best new ICO you can invest in. 

For more information regarding Pullix’s presale see links below:

Visit Pullix

Join The Pullix Communities


This post is sponsored. Finbold neither endorses nor takes responsibility for the accuracy, quality, advertising, products, or other materials on this page. Readers are strongly encouraged to perform their own research before making any decisions regarding the company. Finbold will not be held accountable, either directly or indirectly, for any harm or loss that may stem from or be linked to the usage or reliance on any information, goods, or services mentioned on the page. If you encounter any issues, kindly report them to [email protected].

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.